Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ziarco
Biotech
Novartis dumps Ziarco eczema drug, taking $485M hit
Novartis cut an atopic dermatitis drug from the team—and taking a $485 million impairment charge.
Amirah Al Idrus
Jul 21, 2020 10:40am
Sanofi, Regeneron post more positive dupilumab data
Mar 6, 2017 3:40am
Novartis boosts dermatology pipeline with Ziarco buy
Dec 16, 2016 3:56am
Pfizer-backed dermatology player Ziarco looking to land buyout bid: Bloomberg
Jun 15, 2016 3:50am
Ziarco gears up for Series C, PhIIb to advance atopic dermatitis drug
May 19, 2016 3:10am
